Eurofins Genomics is a leading provider of services in DNA synthesis, DNA sequencing, gene synthesis, genotyping, and bioinformatics.
Creating synthetic DNA involves sequentially adding nucleotide bases, which are the “letters” of life, to generate a specific sequence called oligonucleotide synthesis and genes.
Sequencing is the process of decoding the “letters” of life to assemble a genomic sequence. We serve all sequencing needs under one company, including Nanopore whole plasmid sequencing, Sanger sequencing, and NGS sequencing.
Double-stranded, sequence-verified genes or gene fragments to clone into a vector of your choice.
With facilities in Europe, North America, and Asia, we support clients in the pharma, diagnostics, food, agriculture, biotechnological and research markets with services in DNA synthesis, DNA sequencing, gene synthesis, genotyping, and bioinformatics.
Eurofins Genomics is a global leader in life science products and services and a trusted partner amongst researchers worldwide. Our main production facilities are located in the United States, Europe, Japan, and India. Quality accreditations include ISO 9001, ISO 13485, ISO 17025, GMP, GLP, and more. Eurofins Genomics is known for its speed, quality, and customer-centric culture.
DNA is the language of life. Eurofins Genomics specialises in reading and writing DNA. Writing DNA involves pairing the letters of life together into a sequence, which is designed for a specific purpose. The synthesised sequence is called an oligonucleotide if single-stranded or a gene if double-stranded. Reading DNA revolves around sequencing, a process of decoding the sequence of a sample. This process results in an electronic readout of the sample's contents.